| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |